Related Experiment Videos
Avascular necrosis and bone marrow edema syndrome
Rohan M Watson1, Neil A Roach, Murray K Dalinka
1Division of Musculoskeletal Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Radiologic Clinics of North America
|March 31, 2004
Summary
Magnetic resonance imaging (MRI) accurately diagnoses avascular necrosis (AVN) and related conditions. Early intervention with joint-sparing surgery improves outcomes for AVN, supporting screening in high-risk patients.
Area of Science:
- Orthopedic imaging
- Radiology
- Bone diseases
Background:
- Avascular necrosis (AVN) and bone marrow edema syndrome (TO) are significant causes of hip pain.
- Distinguishing between AVN, TO, and femoral head insufficiency fractures (SIF) is crucial for appropriate treatment.
- Patient demographics and risk factors, such as renal transplant and corticosteroid use, are important considerations.
Purpose of the Study:
- To evaluate the diagnostic accuracy of MR imaging for AVN, TO, and SIF.
- To assess the effectiveness of joint-sparing operative intervention compared to conservative management for early-stage AVN.
- To highlight the need for screening programs in high-risk populations.
Main Methods:
- Review of MR imaging findings in patients with suspected AVN, TO, and SIF.
- Comparison of outcomes between surgical and conservative treatments for early AVN.
- Analysis of patient demographics and risk factors associated with AVN.
Main Results:
- MR imaging demonstrates high accuracy in diagnosing AVN, TO, and SIF, especially when considering patient demographics.
- Joint-sparing operative intervention shows improved outcomes compared to conservative management for early-stage (I, II) AVN.
- Bone marrow edema syndrome (TO) is confirmed as a distinct entity.
- Advanced imaging techniques can differentiate AVN from TO and SIF.
Conclusions:
- MR imaging is the gold standard for diagnosing AVN, TO, and SIF of the femoral head.
- Early surgical intervention for AVN leads to better outcomes.
- Screening for AVN is recommended in high-risk individuals, including transplant recipients and those on long-term corticosteroids.